CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
Transpulmonary thermodilution +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04337983
NCT04337983N/ACompleted

Hemodynamic Characteristics of Patients With SARS-CoV-2: PiCCOVID Study

Bicetre Hospital·observational·Posted Apr 8, 2020·Updated Sep 14, 2021

In Brief

An observational study evaluating Transpulmonary thermodilution and Echocardiography for Coronavirus and 7 related conditions. Completed, enrolled 60 participants across 1 site.

Detailed Summary

The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been declared a public health emergency of international concern. Hospitalized COVID-19-positive patients requiring ICU care is increasing along with the course of epidemic. A large number of these patients developed acute respiratory distress syndrome (ARDS) according to current data. However, the related hemodynamic characteristic has so far been rarely described.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesFrance
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedApr 8, 2020
Enrollment StartMar 13, 2020
Primary CompletionOct 30, 2020
Study CompletionNov 30, 2020
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 6.2 years ago

Interventions

Transpulmonary thermodilutiondevice

Obtained by averaging the results of three thermodilution measurements. Each thermodilution is performed by injecting a bolus (15 mL) of cold saline (less than 10°C)

Echocardiographydevice

Daily echocardiography evaluation